Treatment of benign prostate enlargement

05

Feb 2021

In January 2021, the National Institute for Health and Care Excellence (NICE) published two new interventional procedure guidance (self-expanding implant insertion into the intersphincteric space for faecal incontinence and minimally invasive radical hysterectomy for early stage cervical cancer), two new medical technologies guidance (the PLASMA system for transurethral resection and haemostasis of the prostate, and the VAC Veraflo Therapy system for acute infected or chronic wounds), and six Medtech innovation briefings (Optilume for anterior urethral strictures, AI in mammography, AI for analyzing chest CT images, AcQMap for mapping the heart atria to target ablation treatment, and others). Also, two clinical guidelines were updated. Read more

11

Jun 2020

Since 2020 the use of Prostatic Urethral Lift will be covered by basic health insurance under specific clinical indications. Read more

08

Jun 2020

New codes for Prostatic Urethral Lift system, CT and MRI examination of the neck, fecal microbiota transplant, testicular sperm extraction, implantable rechargeable and a non-rechargeable pulse generator for deep brain stimulation, as well as PET-CT myocardial perfusion with volume, ejection fraction and flow measurements and molecular diagnostics, were implemented in 2020. Read more

18

Dec 2019

At the end of November 2019, the report of the project OTCA17, titled “Lithium triborate (LBO) laser for photoselective vaporization of the prostate (PVP) in the treatment of benign prostatic hyperplasia (BPH)” was published on the website of the European Network for HTA (EUnetHTA). Read more

16

Sep 2019

The report presents a summary of the reimbursement situation for use of minimally invasive treatment of benign prostate enlargement in Europe. The following procedures will be considered under the scope of analysis: transurethral microwave thermotherapy (TUMT), Holmium laser enucleation of the prostate (HoLEP), photoselective vaporization of the prostate, high intensity focused ultrasound (HIFU), Urolift, transurethral resection of the prostate (TURP) as a comparator. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey. Read more